Core Viewpoint - The upcoming 2025 Annual Meeting of Shareholders for Lifeway Foods, Inc. is a critical juncture for the company, with a focus on replacing entrenched board members to enhance governance and shareholder value [3][4]. Group 1: Proxy Statement and Board Changes - Edward Smolyansky has filed a Preliminary Proxy Statement with the SEC to facilitate a comprehensive board change aimed at addressing governance failures and value destruction at Lifeway Foods [1]. - The proxy statement seeks to replace legacy directors responsible for the previous board's lack of accountability and proposes two director nominees, George Sent and Edward Smolyansky, along with a non-binding proposal for a new independent Board committee [2][6]. - The proposed committee would review Lifeway's executive leadership, strategic plan, and alternatives, emphasizing the need for independent oversight [2]. Group 2: Shareholder Engagement and Governance Issues - Smolyansky emphasizes the need for an independent and accountable board, criticizing the current board's dysfunction and failure to serve shareholders effectively [3][4]. - The company has not yet disclosed the appointment of two new Independent Board Members or a definitive date for the 2025 Annual Meeting, raising concerns about governance practices [3]. - Smolyansky urges shareholders to vote for the GREEN Universal Proxy Card to support meaningful change and restore confidence in the company's governance [4].

Core Viewpoint - The majority of retail investors at Cracker Barrel Old Country Store, Inc. expressed their disapproval of CEO Julie Felss-Masino, indicating a lack of confidence in her leadership and calling for her removal [1]. Group 1: Shareholder Sentiment - Retail shareholders overwhelmingly voted against the reelection of CEO Julie Felss-Masino, reflecting their dissatisfaction with her performance and the company's direction [1]. - Biglari Capital argues that the current CEO has not been effective, leading to negative customer traffic, which is expected to continue unless there is a leadership change [1]. Group 2: Index Fund Voting Dynamics - The voting behavior of index funds diverged from that of retail investors, as index funds often delegate voting power to governance departments, which may not align with the economic interests of their clients [1]. - There is a call for index funds to align their voting practices with the interests of non-passive investors, ensuring that the question of leadership effectiveness is adequately addressed [1]. Group 3: Recommendations from Proxy Advisory Firms - Independent proxy advisory firms, including ISS, Glass Lewis, and Egan-Jones, have concluded that a change in leadership is warranted at Cracker Barrel and have recommended voting against the company's nominees [4].

Company Overview - The Cooper Companies operates through two segments: CooperVision, focused on contact lenses, and CooperSurgical, which addresses fertility and women's health care [1][4] - CooperVision accounts for 66% of revenue and is a global leader in contact lens wearers, holding a 26% market share, competing with Johnson & Johnson (37%), Alcon (26%), and Bausch + Lomb (10%) [4] - CooperSurgical contributes 33% of revenue, with 60% from office and surgical services and 40% from fertility services [6] Market Dynamics - The global soft contact lens market is valued at approximately $11 billion, growing at an annual rate of 4% to 6%, driven by a shift to silicone hydrogel 1-day lenses and increasing global contact lens users [5] - The fertility treatment market is a $2 billion global market, also expected to grow at a 4% to 6% pace annually [6] Strategic Challenges - Cooper has been reallocating cash from its profitable contact lens business to CooperSurgical, which has led to declining returns on capital and lower margins in the surgical segment [8][10] - Management changes, particularly the appointment of CEO Albert White, have raised questions about the company's strategic focus, as he previously led CooperSurgical [9] Recent Developments - Jana Partners has taken a position in Cooper and is advocating for strategic alternatives, including a potential merger of its contact lens unit with Bausch + Lomb [3][12] - A merger would not create a market leader, as the combined market share would be 36%, just below Johnson & Johnson's 37% [13] - The complementary nature of the businesses suggests minimal regulatory hurdles for a potential merger [14] Financial Performance - Cooper's share price fell 12.85% following a significant reduction in full-year guidance due to lower-than-expected organic growth in both segments [11] - The company is currently trading at a 12-month forward P/E of 16.4x, a discount compared to its 10-year average of 23.1x [11] Strategic Recommendations - Jana Partners suggests that separating the two business units could yield $300 million to $500 million in synergies, which is substantial for a business generating $850 million in EBITDA [16] - If management resists separation, the focus may shift to leadership changes, potentially appointing a new CEO with expertise in the contact lens industry [17][18]

Core Insights - The fifth annual Palm Beach CorpGov Forum took place on November 5-6, featuring discussions on corporate governance, activism, IPOs, private equity, and venture capital [1] - The event attracted over 300 attendees, including institutional investors, board directors, family offices, attorneys, investment bankers, and key advisors [2] Speaker Highlights - Keynote speaker was Josh Frank, Partner and Co-Investment Officer at Trian Fund Management [3] - Other notable speakers included Andrew Keys from The Ether Machine, Ken Traub from Comtech Telecommunications, and various leaders from law firms and investment groups [3][4][5] Panel Discussions - Panels focused on the impact of market conditions on M&A, shareholder activism, and the role of one-time activists [1]

CorpGov and  IPO Edge are pleased to provide complete video coverage of the fifth annual Palm Beach CorpGov Forum held on Nov. 5-6, featuring a two-day event with panels, firesides and networking receptions. The event comprised an array of speakers from the worlds of corporate governance, activism, IPOs, private equity and venture capital. The panelists discussed the importance of activism both from inside and outside of companies, the role of independent directors, and why shareholder activism and active ...

Core Viewpoint - DOMA Perpetual Capital Management LLC, a significant stockholder of Pacira BioSciences, Inc., is urging the Board to hire bankers and initiate a full sale process for the company due to perceived management underperformance and financial mismanagement [1][2][4]. Financial Performance and Management Concerns - Pacira's management has been criticized for excessive spending, with stock-based compensation projected to be approximately 6% of the company's market capitalization for 2025, exceeding the firm's entire operating income [2][6]. - Year-to-date sales of Zilretta have declined by 2% year over year through Q3, indicating poor business performance [3]. - Revenue growth has been modest at 3% year over year, while expenditures have surged, with R&D costs increasing by 36% and SG&A by 25% year over year [6]. Valuation and Sale Potential - A potential sale could yield a valuation of around $2.7 billion, translating to approximately $66 per share, which is three times the current stock price and represents a reasonable acquisition valuation [4][5]. - The cash flows from Pacira's assets, particularly Exparel, could exceed $10 billion through patent expiration, suggesting significant value under a larger owner [4]. Strategic Recommendations - The company should immediately pursue a sale process, with a target completion date before the end of Q1 2026 [7]. - Cost-cutting strategies must be implemented to enhance shareholder returns, and all new development programs should be put on hold until a sale is explored [12]. - Free cash flow should be prioritized for share buybacks, with a recommendation for a new $300 million buyback program following the completion of the current one [12]. Shareholder Relations and Governance - The Board's actions have been perceived as neglecting shareholder interests, with ongoing dilution of shareholder value through unapproved share issuances [10][11]. - DOMA has been in communication with the Board for over a year, advocating for a shareholder-friendly capital allocation framework, which has only recently begun to materialize [9].

Core Viewpoint - Lifeway Foods' board extended its Shareholder Rights Agreement without shareholder approval, raising concerns about governance and accountability [3][6][8] Group 1: Shareholder Rights Agreement Extension - On October 29, 2025, Lifeway Foods' board approved an amendment to extend the Shareholder Rights Agreement's expiration date to October 29, 2026, without shareholder approval [3] - The extension was perceived as a move to protect entrenched management and directors, undermining shareholder interests [6][7] - The company's recent filings indicated no specific takeover bid prompted this decision, citing only "concentrated ownership" as justification [7] Group 2: Governance Concerns - The timing of the extension coincided with a board refreshment and leadership deadline, suggesting a lack of transparency in governance practices [4][6] - Influential proxy advisory firms have advised against long-term poison pills, particularly those extended without shareholder approval, indicating potential adverse voting recommendations against supporting directors [8] - The extension follows significant ownership concentration by Danone SA, which holds approximately 23% of Lifeway's shares [8] Group 3: Call to Action - Shareholders are urged to demand the immediate rescindment of the Rights Plan amendment and to ensure a transparent voting process regarding board decisions [9] - The company is called to disclose the board vote details and commit to a shareholder vote before any further renewals of the Rights Plan [9] - If the board does not comply, there is a plan to encourage institutional investors and proxy advisory firms to hold responsible directors accountable [10]

Core Insights - HoldCo Asset Management, LP has released a follow-up presentation to the Board of Directors of Columbia Banking System, Inc., highlighting the need for protective covenants due to failed gambles solely borne by owners [1] Company Overview - HoldCo Asset Management, LP is based in Fort Lauderdale, Florida, and manages approximately $2.6 billion in regulatory assets [2] Investment Position - HoldCo disclosed ownership of common stock in Columbia Banking System, Inc., indicating an economic interest in the price of these securities [1][2]

Core Insights - The article discusses the competitive landscape of the investment trust sector in London, highlighting the strategies of activist investors like Daniel Loeb and Joe Bauernfreund, who focus on acquiring shares of companies trading at discounts to their liquidating values [1][2][3]. Group 1: Investment Strategies - AVI Global Trust, managed by Joe Bauernfreund, specializes in buying shares of companies and investment trusts that are undervalued, particularly those with significant assets [3][4]. - The trust has achieved an 11.8% compound annual return over 40 years, outperforming the ACWI global stock index by 2.4 percentage points [6]. - The article suggests that Japan presents a promising market for value investing, with small-company Japanese stocks expected to outperform other asset classes according to GMO's forecasts [6][13]. Group 2: Activist Investor Dynamics - Daniel Loeb's recent merger of his London-listed trust with an offshore insurance company faced opposition from dissident shareholders, leading to increased cash payouts to them [2][15]. - Joe Bauernfreund's approach involves targeting holding companies controlled by wealthy families, which often trade at significant discounts to their liquidating values [4][11]. - The article notes that many investors overlook the value in complex holding companies due to their perceived uninvestability [11]. Group 3: Specific Company Examples - News Corp is highlighted as a prime example of a holding company trading at a 41% discount to its liquidating value, with significant assets like the Wall Street Journal and a 61% stake in REA [5][11]. - Vincent Bolloré's conglomerate and Vivendi are also mentioned as trading at discounts, with Bolloré's complex corporate structure allowing for control over a diverse asset pool [10][11]. - Christian Dior, a holding company with a 2% public float, trades at an 18% discount to its net asset value, with AVI Global Trust holding some of its shares [12]. Group 4: Market Reactions and Future Outlook - The article notes that the French market regulator's ruling on Bolloré SE's entanglement with Vivendi has led to a 14% increase in Vivendi's share price [14]. - AVI Global Trust's strategy includes periodically buying back its own shares to maintain shareholder satisfaction and mitigate the risk of forced liquidation [18][19].

In order to grow our operation, we need investment. So now it's a kind of balance. We reserve some portion for new investment, for growth.And the the other part of it, we return our profit to the our shareholders. And our current market cap is not so satisfactory. So that's one of the points.And we decided to increase the distributions and also the share buybacks. Do you have a target in mind when you think about your market cap. At the moment, PBR is below 1.0%.So then I think at least our company's value, ...